Medical Device Regulatory Consulting Services

Cisema delivers specialized medical device consulting services for international clients looking to access the Chinese and Asia-Pacific markets. With a deep understanding of local regulations, we help medical device manufacturers navigate the full spectrum of regulatory compliance activities. Our bilingual consulting team, located across Europe and Asia, ensures timely, accurate, and fully compliant submission of all required regulatory documents.

Our services include registration, type testing, clinical research, post-market surveillance. Whether you're a digital health startup or a blue-chip in the medical device industry, Cisema offers hands-on support and strategic guidance tailored to your product type—covering devices, combination products, and more.

We go beyond medical device regulatory affairs. As one of the few consulting firms with cross-sector capabilities, we also serve related areas within the healthcare industry such as IVDs, pharmaceuticals, biopharma, cosmetics, health foods, veterinary medicines, and consumer goods. Our integrated approach allows clients to manage compliance across multiple verticals through one trusted partner.

Medical Device Consultant - Cisema
Outsourcing service

Discover our China Medical Device Consulting Services

Whether you’re just starting out or are a blue-chip, access our wide range of services and solutions to help your business thrive in China.

China Medical Device Registration

We guide you through every step of the China medical device registration and filing process. We take care of compliance with NMPA requirements, advising you on the optimal market entry pathway, and helping you through the whole process

Learn more

NMPA Legal Agent

We act as your official representative in China, handling registrations, filings, and ensuring you are fully compliant, including quality assurance and PMS requirements.

Learn more

NMPA Type Testing

We provide end-to-end support for China type testing in NMPA-accredited laboratories. Our experienced test engineers offer on-site supervision to guarantee accurate and reliable results.

Learn more

China Clinical Trials

You may be required to provide supplementary clinical data on Chinese patients or conduct a full clinical trial in China.Our clinical research consultants will advise you, prepare the study protocol and assist setting up the clinical trial in China.

Learn more

NMPA Clinical Evaluation Report

CERs can avoid the need for a China clinical trial in some instances. Our experts can advise and prepare NMPA-compliant CERs.

Learn more

Drug Device Combination Products

We assist with the classification, registration, and compliance of combination products in China, whether drug or device-led.

Learn more

China Medical Device Quality Compliance

We help you achieve and ensure ongoing compliance with Chinese requirements.Our experts prepare and assist you for official NMPA inspections.

Learn more

Medical Device PMS & Vigilance

The NMPA is placing greater focus on Post-Market Surveillance (PMS) such as more in-market sampling inspections and regular standard changes.Our specialist PMS team means you remain fully compliant at all tims.

Learn more

Regulatory Outsourcing

Leverage our team of consultants and subject matter experts for specialized projects or long-term regulatory resource needs.

Learn more
Medical Device Consultant

Our Hong Kong Medical Device 
Consulting Services

Our Hong Kong Medical Device Consulting Services provide targeted support to help you meet regulatory requirements and launch your products with confidence.

Hong Kong Local Responsible Person

We act as your designated Local Responsible Person (LRP), fulfilling listing and PMS obligations under MDACS.

Learn more

Hong Kong Medical Device Registration

We support you through every stage of the Hong Kong Medical Device Listing process. From classification to handling regulatory requirements, we make the process as smooth as possible.

Learn more

Regulatory Outsourcing

If you are seeking specific specialist expertise or have ongoing resource-intensive needs, our team of consultants has a variety of solutions to meet your needs.

Learn more

Discover Our Other Medical Device Consulting Services Across APAC

Malaysia

Singapore

Vietnam

Taiwan

Indonesia

The Philippines

Thailand

South Korea

Medical Device Insights From Cisema

View More

China Medical Device GMP vs ISO 13485: Key Differences Explained

Understand the key differences between China Medical Device GMP and ISO 13485, including requirements for quality management, suppliers, facilities and documentation.

October 15, 2026
China Medical Device GMP vs ISO 13485: Key Differences Explained
Two Chinese medical device technicians, a woman and a man wearing white lab coats, surgical caps, face masks, and protective gloves, stand side by side in a sterile cleanroom environment.

What Is China’s UDI System & How Does It Affect Medical Device Registration?

Learn about China's Unique Device Identification (UDI) system and how to navigate China’s evolving medical device market.

October 12, 2026
What Is China’s UDI System & How Does It Affect Medical Device Registration?

How Does GBA Real World Data Support China NMPA Approvals?

Discover how leveraging Real World Data generated in the Greater Bay Area can accelerate market entry for medical products in China.

October 12, 2026
How Does GBA Real World Data Support China NMPA Approvals?

Guide to Indonesia Medical Device Post-Registration Changes: Notification, Variation, or New Registration

Learn when medical device and IVD changes in Indonesia require a notification, variation, or new registration, and how to maintain ongoing regulatory compliance.

October 12, 2026
Guide to Indonesia Medical Device Post-Registration Changes: Notification, Variation, or New Registration

How Singapore Accelerates ASEAN Market Entry for Medical Devices, Pharma, & Cosmetics

This guide explains Singapore’s HSA regulatory system and why it is a strategic first step for entering Southeast Asian markets with medical devices, pharmaceuticals, and cosmetics.

October 12, 2026
How Singapore Accelerates ASEAN Market Entry for Medical Devices, Pharma, & Cosmetics

China Medical Device Approval Tracker: Imported Class II & III Devices

Track all imported Class II and III medical device approvals in China with this monthly updated NMPA submission tracker.

September 29, 2026
China Medical Device Approval Tracker: Imported Class II & III Devices
Previous
Previous

Other Industries We Support

In addition to medical devices, we offer consulting services across regulated industries including IVDs, pharmaceuticals, biopharma, quasi-drugs, cosmetics, health foods, veterinary products, and other industrial and consumer goods. Our team ensures tailored regulatory compliance strategies, regardless of product category or manufacturing model.

Latest Medical Device Regulatory News

View More

Hong Kong Requires MDACS Listing for Injectable Dermal Fillers by March 1, 2027

New requirements could affect how injectable devices, including dermal fillers, are supplied in Hong Kong’s private healthcare sector.

September 29, 2026
Hong Kong Requires MDACS Listing for Injectable Dermal Fillers by March 1, 2027

China Enacts First Healthcare Security Law: Impact on Global Medtech

China’s new Healthcare Security Law affects medical device reimbursement, health economic evidence, payment models, and digital traceability from 2027.

September 25, 2026
China Enacts First Healthcare Security Law: Impact on Global Medtech

Indonesia Mandates Pre-Shipment Halal Verification for Imported Products

BPJPH Regulation No. 4 of 2026 introduces pre-shipment halal verification and LPPH reports for imported goods starting September 2026.

September 25, 2026
Indonesia Mandates Pre-Shipment Halal Verification for Imported Products

NMPA Issues World’s First Industry Standard for Medical Devices Using/Adopting BCI Technology

China’s NMPA has released YY/T 2029–2026, establishing the world's first AI-BCI EEG dataset quality standard for medical devices ahead of its September 2027 enforcement.

September 23, 2026
NMPA Issues World’s First Industry Standard for Medical Devices Using/Adopting BCI Technology

China Issues First Ethical Guidelines for Artificial Intelligence Medical Imaging Research

China’s Science Ministry issued ethical guidelines establishing strict standards for AI medical imaging data, algorithm validation, and ethics reviews.

September 15, 2026
China Issues First Ethical Guidelines for Artificial Intelligence Medical Imaging Research

TFDA Simplifies Paperwork for Medical Device Applications in Taiwan

From October 1, 2026, TFDA will expand electronic review and stop issuing paper copies of approved labeling for Class I, II, and III medical devices in Taiwan.

September 11, 2026
TFDA Simplifies Paperwork for Medical Device Applications in Taiwan
Previous
Previous

Get in Touch with Our Medical Device Consultants

Speak to our consultants to learn how our comprehensive services, regulatory guidance, and operational expertise can help you stay ahead in the complex medical device regulatory environment of China and Southeast Asia.

Request Proposal